Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
Clinical trial NCT03574818 · TERMINATED
Trial details
- NCT number
- NCT03574818
- Sponsor
- Montefiore Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2018-10-25
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.